Cargando…

Targeting SphK2 Reverses Acquired Resistance of Regorafenib in Hepatocellular Carcinoma

Background: Regorafenib is a second-line therapy drug used for advanced hepatocellular carcinoma (HCC). Unfortunately, the survival benefit of the patients receiving this treatment is modest, which may be attributed to drug resistance. In the present study, sphingosine kinase 2 (SphK2) was targeted...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Weiwei, Zhang, Shan, Ma, Ding, Yan, Dongliang, Zhang, Guang, Cao, Yin, Wang, Zhongxia, Wu, Junhua, Jiang, Chunping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327090/ https://www.ncbi.nlm.nih.gov/pubmed/32670862 http://dx.doi.org/10.3389/fonc.2020.00694

Ejemplares similares

SphK2/S1P Promotes Metastasis of Triple-Negative Breast Cancer Through the PAK1/LIMK1/Cofilin1 Signaling Pathway
por: Shi, Weiwei, et al.
Publicado: (2021)

Mammalian sphingosine kinase (SphK) isoenzymes and isoform expression: challenges for SphK as an oncotarget
por: Hatoum, Diana, et al.
Publicado: (2017)

Therapeutic Potential of SphK1 Inhibitors Based on Abnormal Expression of SphK1 in Inflammatory Immune Related-Diseases
por: Bu, Yanhong, et al.
Publicado: (2021)

Inhibition of SphK1 reduces radiation-induced migration and enhances sensitivity to cetuximab treatment by affecting the EGFR/SphK1 crosstalk
por: Schiefler, Carlotta, et al.
Publicado: (2014)

SphK2 over-expression promotes osteosarcoma cell growth
por: Xu, Dawei, et al.
Publicado: (2017)

Activation of SphK2 contributes to adipocyte-induced EOC cell proliferation
por: Dai, Lan, et al.
Publicado: (2022)

Identification of sphingosine kinase 1 (SphK1) as a primary target of icaritin in hepatocellular carcinoma cells
por: Lu, Pei-Hua, et al.
Publicado: (2017)

Sphingosine Kinase-1 (SphK-1) Regulates Mycobacterium smegmatis Infection in Macrophages
por: Prakash, Hridayesh, et al.
Publicado: (2010)

Pathological roles of the VEGF/SphK pathway in Niemann–Pick type C neurons
por: Lee, Hyun, et al.
Publicado: (2014)

Activation of SphK1 by adipocytes mediates epithelial ovarian cancer cell proliferation
por: Dai, Lan, et al.
Publicado: (2021)

The therapeutic value of the SphK1-targeting microRNA-3677 in human osteosarcoma cells
por: Yao, Chen, et al.
Publicado: (2020)

MiR-124 inhibits the migration and invasion of ovarian cancer cells by targeting SphK1
por: Zhang, Hanwen, et al.
Publicado: (2013)

Activation of the SphK1/ERK/p-ERK pathway promotes autophagy in colon cancer cells
por: Xu, Chunyan, et al.
Publicado: (2018)

Glucocorticoids limit acute lung inflammation in concert with inflammatory stimuli by induction of SphK1
por: Vettorazzi, Sabine, et al.
Publicado: (2015)

Targeting SphK1/2 by SKI-178 inhibits prostate cancer cell growth
por: Jin, Lu, et al.
Publicado: (2023)

Dabigatran Suppresses PAR-1/SphK/S1P Activation of Astrocytes in Experimental Autoimmune Encephalomyelitis Model
por: Chen, Rong, et al.
Publicado: (2020)

Neuronal SphK1 acetylates COX2 and contributes to pathogenesis in a model of Alzheimer’s Disease
por: Lee, Ju Youn, et al.
Publicado: (2018)

Targeting the SphK-S1P-SIPR Pathway as a Potential Therapeutic Approach for COVID-19
por: McGowan, Eileen M, et al.
Publicado: (2020)

SphK1‐driven autophagy potentiates focal adhesion paxillin‐mediated metastasis in colorectal cancer
por: Wu, Jiang‐Ni, et al.
Publicado: (2021)

SphK-produced S1P in somatic cells is indispensable for LH-EGFR signaling-induced mouse oocyte maturation
por: Yuan, Feifei, et al.
Publicado: (2022)

SphK1-targeted miR-6784 inhibits functions of skin squamous cell carcinoma cells
por: Gong, Zhen-Hua, et al.
Publicado: (2021)

Targeting sphingosine kinase 2 (SphK2) by ABC294640 inhibits colorectal cancer cell growth in vitro and in vivo
por: Xun, Cai, et al.
Publicado: (2015)

MicroRNA-613 inhibits cell growth, migration and invasion of papillary thyroid carcinoma by regulating SphK2
por: Qiu, Wangwang, et al.
Publicado: (2016)

MicroRNA-338-3p Suppresses Proliferation of Human Liver Cancer Cells by Targeting SphK2
por: Xiao, Geqiong, et al.
Publicado: (2018)

Spatiotemporal Expression of SphK1 and S1PR2 in the Hippocampus of Pilocarpine Rat Model and the Epileptic Foci of Temporal Lobe Epilepsy
por: Dong, Yuan-Yuan, et al.
Publicado: (2020)

A novel co-target of ACY1 governing plasma membrane translocation of SphK1 contributes to inflammatory and neuropathic pain
por: Liu, Baowen, et al.
Publicado: (2023)

Protective Effect of Protocatechuic Acid on TNBS-Induced Colitis in Mice Is Associated with Modulation of the SphK/S1P Signaling Pathway
por: Crespo, Irene, et al.
Publicado: (2017)

Correction: MicroRNA-613 inhibits cell growth, migration and invasion of papillary thyroid carcinoma by regulating SphK2
por: Qiu, Wangwang, et al.
Publicado: (2022)

Inhibition of SphK1/S1P Signaling Pathway Alleviates Fibrosis and Inflammation of Rat Myocardium after Myocardial Infarction
por: Wu, Xiaokui, et al.
Publicado: (2022)

Long non-coding RNA 00960 promoted the aggressiveness of lung adenocarcinoma via the miR-124a/SphK1 axis
por: Ge, Zhipeng, et al.
Publicado: (2022)

Overexpression of SphK2 contributes to ATRA resistance in colon cancer through rapid degradation of cytoplasmic RXRα by K48/K63-linked polyubiquitination
por: Shi, Wen-Na, et al.
Publicado: (2017)

Essential role for SphK1/S1P signaling to regulate hypoxia-inducible factor 2α expression and activity in cancer
por: Bouquerel, P, et al.
Publicado: (2016)

Effect of the Interaction between Viral PB2 and Host SphK1 on H9N2 AIV Replication in Mammals
por: Zhou, Yong, et al.
Publicado: (2022)

Retracted: Inhibition of SphK1/S1P Signaling Pathway Alleviates Fibrosis and Inflammation of Rat Myocardium after Myocardial Infarction
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Effects of Inhibition of Serine Palmitoyltransferase (SPT) and Sphingosine Kinase 1 (SphK1) on Palmitate Induced Insulin Resistance in L6 Myotubes
por: Mikłosz, Agnieszka, et al.
Publicado: (2013)

Long Noncoding RNA MALAT1 Interacts with miR-124-3p to Modulate Osteosarcoma Progression by Targeting SphK1
por: Liu, Bin, et al.
Publicado: (2021)

Associations of miR-499 and miR-34b/c Polymorphisms with Susceptibility to Hepatocellular Carcinoma: An Evidence-Based Evaluation
por: Wang, Zhongxia, et al.
Publicado: (2013)

SphK1 confers resistance to apoptosis in gastric cancer cells by downregulating Bim via stimulating Akt/FoxO3a signaling
por: XIONG, HUAPING, et al.
Publicado: (2014)

Computational investigation of sphingosine kinase 1 (SphK1) and calcium dependent ERK1/2 activation downstream of VEGFR2 in endothelial cells
por: Bazzazi, Hojjat, et al.
Publicado: (2017)

SphK1/S1P mediates TGF-β1-induced proliferation of pulmonary artery smooth muscle cells and its potential mechanisms
por: Wang, Jian, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8nct3hc1d1ut7fe9etvf9755g9